Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-07-01T08:20:25.797Z Has data issue: false hasContentIssue false

Chapter 36 - Gene Therapy

from SECTION 3 - MOLECULAR THERAPEUTICS

Published online by Cambridge University Press:  04 June 2019

Marc S Weinberg
Affiliation:
PhD, is a senior lecturer in the Division of Molecular Medicine and Haematology, University of the Witwatersrand, and a member of the Antiviral Gene Therapy Research Unit.
Patrick Arbuthnot
Affiliation:
MB BCh, BSc (Hons), PhD, is a reader in the Division of Molecular Medicine and Haematology at the Medical School of the University of the Witwatersrand, Johannesburg. He has a research interest in using nucleic acid transfer to develop new approaches to treating viral infections of South African importance.
Barry Mendelow
Affiliation:
University of the Witwatersrand, Johannesburg
Michèle Ramsay
Affiliation:
University of the Witwatersrand, Johannesburg
Nanthakumarn Chetty
Affiliation:
University of the Witwatersrand, Johannesburg
Wendy Stevens
Affiliation:
University of the Witwatersrand, Johannesburg
Get access

Summary

INTRODUCTION

It is fair to say that almost all diseases, whether acquired or inherited, have at their foundation a genetic aetiology. The understanding of the molecular basis of disease and the recent acquisition of ‘genetic’ tools have made it feasible to consider the notion of repairing damaged genes (e.g. inherited diseases) or removing rogue genetic elements (e.g. cancers, viruses and bacteria) as a viable therapeutic objective. But what is gene therapy? Although definitions may vary, in essence gene therapy refers to any procedure intended to treat or alleviate disease by genetically modifying the cells of a patient. Often, although not always, gene therapy involves the artificial introduction of genetic material (such as DNA or RNA) into cells. Since DNA and RNA are relatively large nucleic acid macromolecules, their successful introduction rests on developing delivery systems that are capable of carrying macro - molecules to diseased cells.

At present gene therapy remains an experimental technique with tremendous promise for the future of medicine. In this chapter different types of gene-based therapeutic approaches are outlined, with the focus being on innovative experimental technologies that are most likely to obtain clinical success. The topic of gene delivery will be discussed by comparing the strengths and weaknesses of viral and non-viral delivery systems

SOMATIC VS GERMLINE GENE THERAPY

Germline gene therapy. This form of gene therapy requires the introduction of genetic material (DNA or RNA) into sperm or oocytes to produce permanent, transmissible modification. Germline gene therapy is considered to be unethical and in some countries is illegal. In addition, this type of intervention may not necessarily solve the problem. For example, for many recessive disorders, carriers maintain the frequency of the dominant allele.

Somatic gene therapy. All current gene therapy treatment modalities aim to introduce genetic material into somatic cells, although, unlike germline therapy, such an approach is unlikely to produce permanent modifications of the targeted cells. Long-term trans mission of genes can be achieved by utilising viral vectors capable of integrating into quiescent (non-dividing) cells or by targeting stem cells.

Type
Chapter
Information
Publisher: Wits University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Gene Therapy
    • By Marc S Weinberg, PhD, is a senior lecturer in the Division of Molecular Medicine and Haematology, University of the Witwatersrand, and a member of the Antiviral Gene Therapy Research Unit., Patrick Arbuthnot, MB BCh, BSc (Hons), PhD, is a reader in the Division of Molecular Medicine and Haematology at the Medical School of the University of the Witwatersrand, Johannesburg. He has a research interest in using nucleic acid transfer to develop new approaches to treating viral infections of South African importance.
  • Edited by Barry Mendelow, University of the Witwatersrand, Johannesburg, Michèle Ramsay, University of the Witwatersrand, Johannesburg, Nanthakumarn Chetty, University of the Witwatersrand, Johannesburg, Wendy Stevens, University of the Witwatersrand, Johannesburg
  • Book: Molecular Medicine for Clinicians
  • Online publication: 04 June 2019
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Gene Therapy
    • By Marc S Weinberg, PhD, is a senior lecturer in the Division of Molecular Medicine and Haematology, University of the Witwatersrand, and a member of the Antiviral Gene Therapy Research Unit., Patrick Arbuthnot, MB BCh, BSc (Hons), PhD, is a reader in the Division of Molecular Medicine and Haematology at the Medical School of the University of the Witwatersrand, Johannesburg. He has a research interest in using nucleic acid transfer to develop new approaches to treating viral infections of South African importance.
  • Edited by Barry Mendelow, University of the Witwatersrand, Johannesburg, Michèle Ramsay, University of the Witwatersrand, Johannesburg, Nanthakumarn Chetty, University of the Witwatersrand, Johannesburg, Wendy Stevens, University of the Witwatersrand, Johannesburg
  • Book: Molecular Medicine for Clinicians
  • Online publication: 04 June 2019
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Gene Therapy
    • By Marc S Weinberg, PhD, is a senior lecturer in the Division of Molecular Medicine and Haematology, University of the Witwatersrand, and a member of the Antiviral Gene Therapy Research Unit., Patrick Arbuthnot, MB BCh, BSc (Hons), PhD, is a reader in the Division of Molecular Medicine and Haematology at the Medical School of the University of the Witwatersrand, Johannesburg. He has a research interest in using nucleic acid transfer to develop new approaches to treating viral infections of South African importance.
  • Edited by Barry Mendelow, University of the Witwatersrand, Johannesburg, Michèle Ramsay, University of the Witwatersrand, Johannesburg, Nanthakumarn Chetty, University of the Witwatersrand, Johannesburg, Wendy Stevens, University of the Witwatersrand, Johannesburg
  • Book: Molecular Medicine for Clinicians
  • Online publication: 04 June 2019
Available formats
×